The influence of refractoriness to adenosine 5'-monophosphate on allergen-provoked bronchoconstriction in asthma
- PMID: 2764368
- DOI: 10.1164/ajrccm/140.2.321
The influence of refractoriness to adenosine 5'-monophosphate on allergen-provoked bronchoconstriction in asthma
Abstract
Repeated bronchoprovocation with adenosine 5'-monophosphate (AMP) in atopic, nonasthmatic subjects produces a state of refractoriness to the nucleotide that may be due either to depletion of preformed mediators from airway mast cells or down-regulation of purinoceptors on the surface of these cells. To investigate this further, we compared the effect on immediate allergen-provoked bronchoconstriction of preceding repeated challenges with histamine and AMP in eight atopic, mildly asthmatic subjects. In three successive AMP concentration-response studies, the geometric mean PC20 AMP increased from 275.3 to 1154.3 (p less than 0.01) and 1976.7 (p less than 0.01) mg/ml, respectively, whereas no significant similar increase in PC20 occurred with repeated histamine challenges. Refractoriness to AMP was not associated with any significant decrease in airways responsiveness to histamine. When compared with the response after repeated provocation with inhaled histamine, repeated exposure of the airways to AMP potentiated, rather than inhibited, immediate allergen-induced bronchoconstriction by a mean 57 +/- 22.6% (p less than 0.05) when the data were expressed as the area under the FEV1-time response curve. The ability of airways that have been rendered less responsive to inhaled AMP to exhibit an increased response to allergen suggests that tachyphylaxis to AMP is unlikely to be caused by depletion of preformed mast cell-derived mediators such as histamine.
Similar articles
-
Adenosine bronchoconstriction in asthma: investigations into its possible mechanism of action.Br J Clin Pharmacol. 1990;30 Suppl 1(Suppl 1):89S-98S. doi: 10.1111/j.1365-2125.1990.tb05474.x. Br J Clin Pharmacol. 1990. PMID: 2268511 Free PMC article. Review.
-
Absence of a late-phase response or increase in histamine responsiveness after bronchial provocation with adenosine 5'-monophosphate in atopic and non-atopic asthma.Clin Sci (Lond). 1988 Oct;75(4):429-36. doi: 10.1042/cs0750429. Clin Sci (Lond). 1988. PMID: 2461826 Clinical Trial.
-
The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5'-monophosphate in nonatopic asthma.Am Rev Respir Dis. 1989 Feb;139(2):463-9. doi: 10.1164/ajrccm/139.2.463. Am Rev Respir Dis. 1989. PMID: 2563320 Clinical Trial.
-
Repeated inhalation of bradykinin attenuates adenosine 5'-monophosphate (AMP) induced bronchoconstriction in asthmatic airways.Eur Respir J. 1992 Jun;5(6):700-6. Eur Respir J. 1992. PMID: 1628727 Clinical Trial.
-
The relationship between mast cell-mediator release and bronchial reactivity in allergic asthma.J Allergy Clin Immunol. 1987 Nov;80(5):703-11. doi: 10.1016/0091-6749(87)90291-0. J Allergy Clin Immunol. 1987. PMID: 2445803 Review.
Cited by
-
The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma.Br J Pharmacol. 2005 Aug;145(8):1009-15. doi: 10.1038/sj.bjp.0706272. Br J Pharmacol. 2005. PMID: 15980878 Free PMC article.
-
Cross refractoriness between sodium metabisulphite and exercise induced asthma.Thorax. 1994 Mar;49(3):245-9. doi: 10.1136/thx.49.3.245. Thorax. 1994. PMID: 8202881 Free PMC article.
-
Airway hyper- or hyporeactivity to inhaled spasmogens 24 h after ovalbumin challenge of sensitized guinea-pigs.Br J Pharmacol. 1995 Nov;116(5):2351-8. doi: 10.1111/j.1476-5381.1995.tb15079.x. Br J Pharmacol. 1995. PMID: 8581268 Free PMC article.
-
The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics.Br J Clin Pharmacol. 2008 Aug;66(2):261-5. doi: 10.1111/j.1365-2125.2008.03186.x. Epub 2008 May 27. Br J Clin Pharmacol. 2008. PMID: 18507658 Free PMC article. Clinical Trial.
-
Adenosine bronchoconstriction in asthma: investigations into its possible mechanism of action.Br J Clin Pharmacol. 1990;30 Suppl 1(Suppl 1):89S-98S. doi: 10.1111/j.1365-2125.1990.tb05474.x. Br J Clin Pharmacol. 1990. PMID: 2268511 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical